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I.  General 
 
The following reagents were purchased and used as received: 9-BBN dimer (Aldrich), 
NiBr2•diglyme (Aldrich; somewhat hygroscopic), KOt-Bu (Acros), i-BuOH (anhydrous, 
Aldrich), and i-Pr2O (anhydrous, Aldrich).  Molecular sieves (4 Å, powdered, <5 µ; Aldrich) 
were flame-dried.  Ligand (+)-1 was synthesized according to a procedure by Alper1 and 
purified by flash chromatography (it is also available from Acros). 
 
 
II.  Suzuki Cross-Coupling Reactions 
 
General procedure for the preparation of the boron reagent.  9-BBN dimer (220 mg, 0.90 
mmol) was added to a flask (equipped with a side arm and a stir bar), which was then sealed 
with a septum and successively evacuated and back-filled with argon three times.  i-Pr2O (0.75 
mL) and the alkene (1.8 mmol) were added, and the reaction mixture was stirred at 60 °C for 1 
h.  Next, the mixture was allowed to cool to r.t., and then KOt-Bu (150 mg, 1.2 mmol) and i-
BuOH (180 µL, 2.0 mmol) were added in single portions under a positive pressure of argon.  The 
resulting solution was stirred under argon for 30 min. 
 
                                                
(1)  Kuznetsov, V. F.; Jefferson, G. R.; Yap, G. P. A.; Alper, H. Organometallics 2002, 21, 4241–
4248. 
  S–2 
General procedure for the Suzuki reaction.  NiBr2•diglyme (21 mg, 0.060 mmol) and 4 Å 
molecular sieves (200 mg) were added to a 5-mL oven-dried round-bottom flask (equipped with 
a stir bar), which was then sealed with a septum and successively evacuated and back-filled 
with argon three times.  i-Pr2O (0.8 mL) was added, followed by ligand 1 (18 µL, 0.080 mmol).  
The mixture was stirred for 30 min, resulting in the formation of a pale-blue slurry.  Next, the 
alkyl halide (1.0 mmol) and then the solution of the boron reagent (1.5 M; 1.8 mmol) were added 
by syringe.  The reaction mixture was stirred vigorously at room temperature for 48 h.  Then, it 
was passed through a short plug of silica gel, eluting with 1:1 Et2O/hexanes.  The solvent was 
removed, and the product was purified by flash chromatography. 
 
 
Ph
 
(3-Cyclohexylpropyl)benzene (Table 2, entry 1) [170661-44-6].  Cyclohexyl chloride (119 µL, 
1.0 mmol) and a solution of the boron reagent prepared by hydroboration of allylbenzene with 
9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The product was purified 
by flash chromatography (cyclohexane).  Colorless oil.  First run: 160 mg (79%).  Second run: 162 
mg (80%). 
TLC: Rf = 0.7 (cyclohexane; PMA). 
1H NMR (400 MHz, CDCl3) δ 7.30-7.24 (m, 2H), 7.21-7.14 (m, 3H), 2.56 (t, 2H, J = 7.8 Hz), 
1.75-1.59 (m, 7H), 1.30-1.07 (m, 6H), 0.97-0.80 (m, 2H). 
13C NMR (100 MHz, CDCl3) δ 143.0, 128.4, 128.2, 125.6, 37.6, 37.2, 36.3, 33.4, 28.8, 26.7, 26.4. 
FT-IR (neat) 2958, 2930, 2859, 1496, 1454, 745, 697 cm–1. 
MS (EI) m/z (M+) calcd for C15H22: 202.2, found: 202.2. 
 
 
OEt
Ph  
trans-(3-(2-Ethoxycyclohexyl)propyl)benzene (Table 2, entry 2).  trans-1-Chloro-2-
ethoxycyclohexane (163 mg, 1.0 mmol; prepared according to a literature procedure2) and a 
solution of the boron reagent prepared by hydroboration of allylbenzene with 9-BBN dimer (1.5 
M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The product was purified by flash 
chromatography (2%→5% EtOAc/hexanes).  Clear oil.  First run: 166 mg (67%).  Second run: 
176 mg (71%). 
TLC: Rf = 0.55 (10% EtOAc/hexanes; PMA). 
                                                
(2)  Mendonca, G. F.; Sanseverino, A. M.; De Mattos, M. C. S. Synthesis 2003, 45–48. 
  S–3 
1H NMR (400 MHz, CDCl3) δ 7.30-7.24 (m, 2H), 7.20-7.14 (m, 3H), 3.68-3.60 (m, 1H), 3.37-3.29 
(m, 1H), 2.85-2.77 (m, 1H), 2.68-2.51 (m, 2H), 2.07-2.01 (m, 1H), 1.87-1.50 (m, 7H), 1.37-1.07 (m, 
5H), 1.17 (t, 3H, J = 7.0 Hz). 
13C NMR (100 MHz, CDCl3) δ 143.2, 128.5, 128.3, 125.6, 82.2, 64.1, 43.2, 36.6, 32.2, 31.6, 30.6, 
28.9, 25.6, 24.9, 15.8. 
FT-IR (neat) 2928, 2858, 1496, 1449, 1104, 747, 698 cm–1. 
MS (EI) m/z (M+) calcd for C17H26O: 246.2, found: 246.2. 
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Me
Me
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(3-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)propyl)benzene (Table 2, entry 3).  (–)-
Menthyl chloride (187 µL, 1.0 mmol) and a solution of the boron reagent prepared by 
hydroboration of allylbenzene with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) 
were used.  The product was purified by flash chromatography (cyclohexane).  Clear oil.  First 
run: 135 mg (52%).  Second run: 140 mg (54%). 
TLC: Rf = 0.7 (cyclohexane; PMA). 
1H NMR (400 MHz, CDCl3) δ 7.31-7.25 (m, 2H), 7.21-7.15 (m, 3H), 2.66-2.49 (m, 2H), 2.00-1.90 
(m, 1H), 1.75-1.40 (m, 6H), 1.35-1.05 (m, 3H), 1.11-0.72 (m, 9H), 0.70 (d, 3H, J = 6.9 Hz), 0.70-0.59 
(m, 1H). 
13C NMR (100 MHz, CDCl3) δ 143.1, 128.5, 128.3, 125.7, 46.7, 41.4, 38.8, 36.7, 35.5, 33.0, 32.6, 
28.0, 26.5, 24.5, 23.0, 21.8, 15.4. 
FT-IR (neat) 2954, 2928, 2866, 1453, 1368, 745, 698 cm–1. 
MS (EI) m/z (M+) calcd for C19H30: 258.2, found: 258.3. 
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3-(3-Phenylpropyl)cholest-5-ene (Table 2, entry 4).  Cholesteryl chloride (405 mg, 1.0 mmol) 
and a solution of the boron reagent prepared by hydroboration of allylbenzene with 9-BBN 
dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The product was purified by 
  S–4 
flash chromatography (hexanes).  Waxy solid.  mp 65–70 °C.  First run: 326 mg (67%).  Second 
run: 328 mg (67%).  The product was isolated as a 2:1 (β:α) mixture of two diastereomers.3 
TLC: Rf = 0.5 (hexanes; PMA). 
1H NMR (400 MHz, CDCl3) δ 7.30-7.25 (m, 2H), 7.20-7.14 (m, 3H), 5.29-5.25 (m, 1H, major 
diastereomer), 5.23-5.20 (m, 1H, minor diastereomer), 2.58 (t, 2H, J = 8.4 Hz), 2.10-1.85 (m, 45H), 
0.67 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (both diastereomers) 143.7, 143.0, 128.50, 128.47, 128.4, 128.3, 
125.7, 119.3, 57.0, 56.3, 50.6, 42.4, 40.0, 39.8, 39.6, 39.4, 37.5, 37.4, 37.0, 36.4, 36.3, 35.9, 34.2, 32.0, 
29.3, 28.9, 28.4, 28.2, 24.4, 24.0, 23.0, 22.7, 21.0, 19.6, 18.8, 12.0. 
FT-IR (neat) 2933, 2867, 1461, 1376, 746, 648 cm–1. 
MS (EI) m/z (M+) calcd for C36H56: 488.4, found: 488.5. 
 
 
Ph
CbzN  
Benzyl 4-(3-phenylpropyl)piperidine-1-carboxylate (Table 2, entry 5).  Benzyl 4-
chloropiperidine-1-carboxylate (254 mg, 1.0 mmol) and a solution of the boron reagent prepared 
by hydroboration of allylbenzene with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) 
were used.  The product was purified by flash chromatography (5%→15% EtOAc/hexanes).  
White solid.  mp 150 °C (dec).  First run: 240 mg (71%).  Second run: 229 mg (68%). 
TLC: Rf = 0.15 (10% EtOAc/hexanes; PMA). 
1H NMR (400 MHz, CDCl3) δ 7.40-7.20 (m, 7H), 7.20-7.10 (m, 3H), 5.11 (s, 2H), 4.15 (br s, 2H), 
2.74 (br s, 2H), 2.59 (t, 2H, 7.6 Hz), 1.80-1.55 (m, 4H), 1.50-1.34 (m, 1H), 1.32-1.24 (m, 2H), 1.16-
1.04 (m, 2H). 
13C NMR (100 MHz, CDCl3) δ 155.4, 142.6, 137.1, 128.6, 128.45, 128.39, 128.0, 127.9, 125.8, 67.0, 
45.0, 44.4, 36.2, 35.9, 28.6, 24.5. 
FT-IR (neat) 2931, 2856, 1700, 1430, 1235, 749, 698 cm–1. 
MS (ESI) m/z (M+) calcd for C22H27NO2: 337.2, found: 338.2 (M + H+), 360.2 (M + Na+). 
 
 
Ph
O  
4-(3-Phenylproply)tetrahydro-2H-pyran (Table 2, entry 6).  4-Chlorotetrahydro-pyran (108 
µL, 1.0 mmol) and a solution of the boron reagent prepared by hydroboration of allylbenzene 
with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The product was 
purified by flash chromatography (5%→15% EtOAc/hexanes).  Colorless oil.  First run: 149 mg 
(73%).  Second run: 141 mg (69%). 
                                                
(3) The stereochemistry was assigned by analogy to: Okamura, W. H.; Mitra, M. N.; Pirio, M. 
R.; Mourino, A.; Carey, S. C.; Norman, A. W. J. Org. Chem. 1978, 43, 574–580. 
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TLC: Rf = 0.25 (10% EtOAc/hexanes; PMA). 
1H NMR (400 MHz, CDCl3) δ 7.30-7.24 (m, 2H), 7.20-7.14 (m, 3H), 3.93 (ddd, 2H, J = 11.5, 4.7, 
1.2 Hz), 3.35 (td, 2H, 12.0, 1.8 Hz), 2.59 (t, 2H, 7.7 Hz), 1.70-1.42 (m, 5H), 1.35-1.20 (m, 4H). 
13C NMR (100 MHz, CDCl3) δ 142.8, 128.5, 128.4, 125.8, 68.3, 36.7, 36.2, 35.1, 33.3, 28.4. 
FT-IR (neat) 2928, 2842, 1096, 748, 699 cm–1. 
MS (EI) m/z (M+) calcd for C14H20O: 204.2, found: 204.2. 
 
 
 
Me
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(4-Ethylheptyl)benzene (Table 2, entry 7).  3-Chlorohexane (139 µL, 1.0 mmol) and a 
solution of the boron reagent prepared by hydroboration of allylbenzene with 9-BBN dimer (1.5 
M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The product was purified by flash 
chromatography (cyclohexane).  Colorless oil.  First run: 145 mg (71%).  Second run: 149 mg 
(73%). 
TLC: Rf = 0.65 (cyclohexane; PMA). 
1H NMR (400 MHz, CDCl3) δ 7.31-7.25 (m, 2H), 7.21-7.15 (m, 3H), 2.58 (t, 2H, J = 7.7 Hz), 
1.64-1.52 (m, 2H), 1.34-1.17 (m, 9H), 0.92-0.78 (m, 6H). 
13C NMR (100 MHz, CDCl3) δ 143.1, 128.5, 128.3, 125.7, 38.7, 36.6, 35.7, 33.0, 28.8, 26.0, 20.0, 
14.6, 11.0. 
FT-IR (neat) 2958, 2930, 1495, 1454, 746, 697 cm–1. 
MS (EI) m/z (M+) calcd for C15H24: 204.2, found: 204.3. 
 
 
Me
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tert-Butyl(5-ethyloctyloxy)dimethylsilane (Table 2, entry 8).  3-Chlorohexane (139 µL, 1.0 
mmol) and a solution of the boron reagent prepared by hydroboration of (but-3-enyloxy)(tert-
butyl)dimethylsilane (prepared according to a literature procedure4) with 9-BBN dimer (1.5 M 
solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The product was purified by flash 
chromatography (hexanes).  Colorless oil.  First run: 180 mg (66%).  Second run: 172 mg (63%). 
TLC: Rf = 0.3 (hexanes; PMA). 
1H NMR (400 MHz, CDCl3) δ 3.60 (t, 2H, J = 6.6 Hz), 1.55-1.45 (m, 2H), 1.38-1.15 (m, 11H), 
0.88 (s, 9H), 0.87 (t, 3H, J = 7.2 Hz), 0.82 (t, 3H, J = 7.3 Hz), 0.05 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 63.4, 38.8, 35.7, 33.5, 33.1, 26.1, 26.0, 23.0, 20.0, 18.5, 14.5, 11.0, –
5.1. 
                                                
(4) Ferrie, L.; Reymond, S.; Capdevielle, P.; Cossy, J. Org. Lett. 2007, 9, 2461–2464. 
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FT-IR (neat) 2958, 2930, 2860, 1463, 1255, 1102, 836, 774 cm–1. 
MS (EI) m/z (M+) calcd C16H36OSi: 272.2, found: 215.2 (M+ – t-Bu). 
 
 
Me
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(4-Ethylheptyloxy)triisopropylsilane (Table 2, entry 9).  3-Chlorohexane (139 µL, 1.0 mmol) 
and a solution of the boron reagent prepared by hydroboration of allyloxytriisopropylsilane 
(prepared according to a literature procedure5) with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 
mL, 1.8 mmol) were used.  The product was purified by flash chromatography (hexanes).  
Colorless oil.  First run: 189 mg (63%).  Second run: 198 mg (66%). 
TLC: Rf = 0.3 (hexanes; PMA). 
1H NMR (400 MHz, CDCl3) δ 3.65 (t, 2H, J = 6.9 Hz), 1.56-1.46 (m, 2H), 1.34-1.16 (m, 9H), 
1.14-1.00 (m, 21H), 0.87 (t, 3H, J = 6.8 Hz), 0.83 (t, 3H, J = 7.3 Hz). 
13C NMR (100 MHz, CDCl3) δ 64.1, 38.6, 35.7, 30.3, 29.1, 26.0, 20.0, 18.2, 14.6, 12.2, 11.0. 
FT-IR (neat) 2959, 2942, 2867, 1464, 1105, 883 cm-1. 
MS (EI) m/z (M+) calcd for C18H40OSi: 300.3, found: 257.3 (M+ – i-Pr). 
 
 
Me
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(3-Ethylnonyl)benzene (Table 2, entry 10).  (3-Chloropentyl)benzene (183 mg, 1.0 mmol) 
and a solution of the boron reagent prepared by hydroboration of 1-hexene with 9-BBN dimer 
(1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The product was purified by flash 
chromatography (hexanes).  Colorless oil.  First run: 170 mg (73%).  Second run: 172 mg (74%). 
TLC: Rf = 0.7 (hexanes; UV). 
1H NMR (400 MHz, CDCl3) δ 7.31-7.25 (m, 2H), 7.21-7.15 (m, 3H), 2.58 (t, 2H, J = 7.8 Hz), 
1.67-1.51 (m, 2H), 1.40-1.20 (m, 13H), 0.92-0.80 (m, 6H). 
13C NMR (100 MHz, CDCl3) δ 143.5, 128.5, 128.4, 125.6, 38.8, 35.4, 33.3, 33.2, 32.1, 29.9, 26.7, 
25.9, 22.8, 14.3, 10.9. 
FT-IR (neat) 2959, 2925, 2857, 1454, 743, 697 cm–1. 
MS (EI) m/z (M+) calcd for C17H28: 232.2, found: 232.3. 
 
 
                                                
(5) Frye, S. V.; Eliel, E. L. J. Am Chem. Soc. 1988, 110, 484–489. 
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Me
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Ethyl 4-(4-ethyl-6-phenylhexyl)benzoate (Table 2, entry 11).  (3-Chloropentyl)benzene (183 
mg, 1.0 mmol) and a solution of the boron reagent prepared by hydroboration of ethyl 4-
allylbenzoate (prepared according to a literature procedure6) with 9-BBN dimer (1.5 M solution 
in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The product was purified by flash chromatography 
(5%→10% EtOAc/hexanes).  Colorless oil.  First run: 230 mg (71%).  Second run: 234 mg (72%). 
TLC: Rf = 0.3 (10% EtOAc/hexanes; PMA). 
1H NMR (400 MHz, CDCl3) δ 7.94-7.89 (m, 2H), 7.30-7.20 (m, 4H), 7.20-7.10 (m, 3H), 4.33 (q, 
2H, J = 7.1 Hz), 2.61 (t, 2H, J = 7.6 Hz), 2.52 (dd, 2H, J = 12.4, 5.5 Hz), 1.65-1.48 (m, 4H), 1.34 (t, 
3H, J = 7.2 Hz), 1.40-1.23 (m, 5H), 0.82 (t, 3H, J = 7.0 Hz). 
13C NMR (100 MHz, CDCl3) δ 166.9, 148.4, 143.2, 129.7, 128.6, 128.5, 128.45, 128.42, 125.7, 60.9, 
38.5, 36.5, 35.2, 33.3, 32.7, 28.3, 25.8, 14.5, 10.9. 
FT-IR (neat) 2933, 2859, 1718, 1275, 1106, 761, 699 cm–1. 
MS (EI) m/z (M+) calcd for C23H30O2: 338.2, found: 338.3. 
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Methyl 6-(2-(1,3-dioxan-2-yl)ethyl)-3,3-dimethyl-8-phenyloctanoate (Table 2, entry 12).  2-
(3-Chloro-5-phenylpentyl)-1,3-dioxane (139 µL, 1.0 mmol) and a solution of the boron reagent 
prepared by hydroboration of 3,3-dimethyl-pent-4-enoic acid methyl ester with 9-BBN dimer 
(1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The product was purified by flash 
chromatography (CH2Cl2→7.5% EtOAc/CH2Cl2).  Colorless oil.  First run: 309 mg (82%).  
Second run: 301 mg (80%). 
TLC: Rf = 0.5 (20% EtOAc/hexanes; PMA). 
1H NMR (400 MHz, CDCl3) δ 7.30-7.23 (m, 2H), 7.19-7.13 (m, 3H), 4.83 (t, 1H, J = 5.2 Hz), 
4.13-4.07 (m, 2H), 3.76 (td, 2H, J = 11.8, 1.9 Hz), 3.63 (s, 3H), 2.61-2.54 (m, 2H), 2.14-2.01 (m, 1H), 
1.62-1.50 (m, 5H), 1.42-1.24 (m, 9H), 0.98 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 172.9, 143.1, 128.5, 128.4, 125.7, 102.8, 67.0, 51.2, 45.8, 38.9, 37.6, 
35.5, 33.3, 33.1, 32.6, 27.6, 27.5, 27.4, 26.0. 
FT-IR (neat) 2954, 2856, 1736, 1145, 746, 700 cm–1. 
                                                
(6)  Piazza, C.; Knochel, P. Angew. Chem., Int. Ed. 2002, 41, 3263–3265. 
  S–8 
MS (EI) m/z (M+) calcd for C23H36O4: 376.3, found: 375.3 (M+ – H). 
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2-(6-(4-Methoxyphenyl)-3-phenethylhexyl)-1,3-dioxane (Table 2, entry 13).  2-(3-Chloro-5-
phenylpentyl)-1,3-dioxane (139 µL, 1.0 mmol) and a solution of the boron reagent prepared by 
hydroboration of 4-allylanisole with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) 
were used.  The product was purified by flash chromatography (5%→10% EtOAc/hexanes).  
Colorless oil.  First run: 314 mg (82%).  Second run: 321 mg (84%). 
TLC: Rf = 0.5 (10% EtOAc/hexanes; PMA). 
1H NMR (400 MHz, CDCl3) δ 7.28-7.22 (m, 2H), 7.18-7.12 (m, 3H), 7.09-7.05 (m, 2H), 6.84-6.79 
(m, 2H), 4.46 (t, 1H, J = 5.2 Hz), 4.12-4.06 (m, 2H), 3.78 (s, 3H), 3.77-3.69 (m, 2H), 2.60-2.47 (m, 
4H), 2.14-2.00 (m, 1H), 1.62-1.51 (m, 6H), 1.45-1.29 (m, 6H). 
13C NMR (100 MHz, CDCl3) δ 157.7, 143.1, 135.0, 129.4, 128.5, 128.4, 125.7, 113.8, 102.8, 83.8, 
67.0, 55.4, 36.9, 35.5, 33.1, 33.0, 32.4, 28.8, 27.5, 26.0. 
FT-IR (neat) 2928, 2856, 1512, 1245, 748, 700 cm–1. 
MS (EI) m/z (M+) calcd for C25H34O3: 382.2, found: 382.2. 
 
 
Ph
 
(3-Cyclohexylpropyl)benzene (Table 3, entry 1) [170661-44-6].  Cyclohexyl bromide (163 
mg, 1.0 mmol) and a solution of the boron reagent prepared by hydroboration of allylbenzene 
with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  First run: 152 mg 
(75%).  Second run: 151 mg (75%). 
Table 3, entry 2.  Cyclohexyl iodide (210 mg, 1.0 mmol) and a solution of the boron reagent 
prepared by hydroboration of allylbenzene with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 
1.8 mmol) were used.  First run: 148 mg (73%).  Second run: 158 mg (78%). 
 
 
Ph
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Benzyl 4-(3-phenylpropyl)piperidine-1-carboxylate (Table 3, entry 3).  Benzyl 4-
bromopiperidine-1-carboxylate (298 mg, 1.0 mmol) and a solution of the boron reagent prepared 
  S–9 
by hydroboration of allylbenzene with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) 
were used.  First run: 217 mg (64%).  Second run: 221 mg (66%). 
Table 3, entry 4.  Benzyl 4-iodopiperidine-1-carboxylate (345 mg, 1.0 mmol) and a solution 
of the boron reagent prepared by hydroboration of allylbenzene with 9-BBN dimer (1.5 M 
solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  First run: 216 mg (64%).  Second run: 220 mg 
(65%). 
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4-(3-Phenylproply)tetrahydro-2H-pyran (Table 3, entry 5).  4-Bromotetrahydropyran (165 
mg, 1.0 mmol) and a solution of the boron reagent prepared by hydroboration of allylbenzene 
with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  First run: 144 mg 
(71%).  156 mg (76%). 
Table 3, entry 6.  4-Iodotetrahydropyran (212 mg, 1.0 mmol) and a solution of the boron 
reagent prepared by hydroboration of allylbenzene with 9-BBN dimer (1.5 M solution in i-Pr2O; 
1.2 mL, 1.8 mmol) were used.  First run: 159 mg (78%).  155 mg (75%). 
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Ethyl 4-(4-ethyl-6-phenylhexyl)benzoate (Table 3, entry 7).  (3-Bromopentyl)benzene (227 
mg, 1.0 mmol) and a solution of the boron reagent prepared by hydroboration of ethyl 4-
allylbenzoate (prepared according to a literature procedure6) with 9-BBN dimer (1.5 M solution 
in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  First run: 260 mg (77%).  Second run: 251 mg (74%). 
Table 3, entry 8.  (3-Iodopentyl)benzene (274 mg, 1.0 mmol) and a solution of the boron 
reagent prepared by hydroboration of ethyl 4-allylbenzoate (prepared according to a literature 
procedure6) with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  First run: 
254 mg (75%).  Second run: 265 mg (78%). 
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8-Cyclohexyloctyl 4-methylbenzenesulfonate (Table 3, entry 9).  5-Chloropentyl 4-
methylbenzenesulfonate (277 mg, 1.0 mmol) and a solution of the boron reagent prepared by 
hydroboration of allylcyclohexane with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 
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mmol) were used.  The product was purified by flash chromatography (5% Et2O/hexanes).  
Colorless oil.  First run: 236 mg (64%).  Second run: 230 mg (62%). 
TLC: Rf = 0.5 (25% Et2O/hexanes; KMnO4). 
1H NMR (CDCl3) δ 7.78 (d, 2H, J = 8.3 Hz), 7.34 (d, 2H, J = 8.3 Hz), 4.01 (t, 2H, J = 6.5 Hz), 2.44 
(s, 3H), 1.71-1.55 (m, 7H), 1.32-1.07 (m, 16H), 0.90-0.78 (m, 2H). 
13C NMR (CDCl3) δ 144.7, 133.6, 129.9, 128.0, 70.8, 37.8, 37.6, 33.6, 29.9, 29.5, 29.0, 28.9, 26.90, 
26.87, 26.6, 25.4, 21.7. 
FT-IR (neat) 3063, 3027, 2986, 2933, 2858, 1604, 1496, 1454, 1378, 1369, 1248, 1215, 1156, 1055, 
859, 747, 699 cm–1. 
MS (ESI) m/z (M+) calcd for C21H34O3S: 366.2, found: 384.3 (M+ + NH4). 
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2-(5-(4-Fluorophenyl)pentyl)-1,3-dioxane (Table 3, entry 10).  2-(2-Bromoethyl)-1,3-dioxane 
(195 mg, 1.0 mmol) and a solution of the boron reagent prepared by hydroboration of 1-allyl-4-
fluorobenzene with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) were used.  The 
product was purified by flash chromatography (5% Et2O/hexanes).  Pale-yellow oil.  First run: 
172 mg (68%).  Second run: 181 mg (72%). 
TLC: Rf = 0.3 (25% Et2O/hexanes; UV). 
1H NMR (CDCl3) δ 7.13-7.07 (m, 2H), 6.98-6.91 (m, 2H), 4.49 (t, 1H, J = 5.1 Hz), 4.12-4.06 (m, 
2H), 3.79-3.70 (m, 2H), 2.56 (t, 2H, J = 7.6 Hz), 2.15-2.00 (m, 1H), 1.64-1.54 (m, 4H), 1.46-1.28 (m, 
5H). 
13C NMR (CDCl3) δ 129.8, 129.7, 115.2, 114.9, 102.4, 67.0, 35.3, 35.1, 31.6, 29.1, 26.0, 23.9. 
FT-IR (neat) 2929, 2855, 1601, 1510, 1221, 1146, 998, 824 cm–1. 
MS (EI) m/z (M+) calcd for C15H21FO2: 252.2, found: 251.1 (M+ – H). 
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2,2-Dimethyl-4-(5-phenylpentyl)-1,3-dioxolane (Table 3, entry 11).  4-(2-Iodoethyl)-2,2-
dimethyl-1,3-dioxolane (256 mg, 1.0 mmol) and a solution of the boron reagent prepared by 
hydroboration of allylbenzene with 9-BBN dimer (1.5 M solution in i-Pr2O; 1.2 mL, 1.8 mmol) 
were used.  The product was purified by flash chromatography (5% Et2O/hexanes).  Colorless 
oil.  First run: 198 mg (79%).  Second run: 194 mg (78%). 
TLC: Rf = 0.5 (25% Et2O/hexanes; KMnO4). 
1H NMR (CDCl3) δ 7.31-7.25 (m, 2H), 7.20-7.15 (m, 3H), 4.10-4.00 (m, 2H), 3.49 (t, 1H, J = 7.1 
Hz), 2.61 (t, 2H, J = 7.6 Hz), 1.72-1.54 (m, 3H), 1.54-1.18 (m, 11H). 
  S–11 
13C NMR (CDCl3) δ 142.8, 128.5, 128.4, 125.8, 108.7, 76.2, 69.7, 36.0, 33.7, 31.5, 29.4, 27.1, 25.9, 
25.8. 
FT-IR (neat) 3063, 3027, 2986, 2933, 2858, 1604, 1496, 1454, 1378, 1369, 1248, 1215, 1156, 1055, 
859, 747, 699 cm–1. 
MS (EI) m/z (M+) calcd for C16H24O2: 248.2, found: 248.2. 
 
 
III.  Kinetics Data 
 
General procedure for the preparation of the boron reagent.  In a glovebox, 9-BBN dimer 
(1.10 g, 4.5 mmol), i-Pr2O (3.75 mL), and allylbenzene (1.19 mL, 9.0 mmol) were added to a 20-
mL vial equipped with a stir bar.  Then, the vial was capped, and the reaction mixture was 
stirred vigorously at 60 °C for 1 h.  Next, the mixture was allowed to cool to r.t. and diluted with 
i-Pr2O (6 mL).  Then, KOt-Bu (0.73 g, 6.0 mmol) and i-BuOH (0.92 mL, 10 mmol) were added, 
and the resulting mixture was stirred at r.t. for 30 min. 
General procedure for the Suzuki reaction.  NiBr2•diglyme (4.2 mg, 0.012 mmol), ligand 1 
(3.6 µL, 0.016 mmol), and i-Pr2O (0.10 mL) were added to a 4-mL vial equipped with a stir bar.  
The mixture was stirred for 30 min, resulting in the formation of a pale-blue slurry.  Next, a 
solution of cyclohexyl bromide and tetradecane (calibrated internal standard) in i-Pr2O were 
added, followed by the solution of the boron reagent.  The reaction mixture was stirred 
vigorously at room temperature.  Aliquots (100 µL) were removed after 5, 10, 15, and 20 
minutes, and the amount of product was determined by GC analysis. The initial rates were 
determined by best fit of data from the first 20 minutes of reaction. 
 
Order in the catalyst.  Reactions were run with [electrophile]0 = 0.37 M and [nucleophile]0 = 
0.67 M. 
Table S1.  Observed initial rates as a function of catalyst concentration. 
[catalyst]0 
(mM)  
 rateobs 
(M/h) 
0  0 
11  0.21 
22  0.34 
33  0.63 
44  0.86 
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Order in the nucleophile.  Reactions were run with [catalyst]0 = 0.022 M and [electrophile]0 
= 1.5 M. 
Table S2.  Observed initial rates as a function of nucleophile concentration. 
[nucleophile]0 
(mM)  
 rateobs 
(M/h) 
0  0 
210  0.058 
420  0.11 
620  0.17 
 
The rate of the reaction was not well-behaved at a higher concentration of nucleophile. 
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Order in the Electrophile.  Reactions were run with [catalyst]0 = 0.015 M and [nucleophile]0 
= 0.92 M. 
Table S3.  Observed initial rates as a function of electrophile concentration. 
[electrophile]0 
(mM)  
 rateobs 
(M/h) 
0  0 
64  0.16 
130  0.22 
190  0.17 
260  0.23 
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IV.  1H NMR Spectra 
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